Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53

Molecular Cell

Volumn 3, Issue 5, 1999, Pages 579-591

  Zhang, Yanping ^b   Xiong, Yue ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EXON; GENE MUTATION; HELA CELL; HUMAN; HUMAN CELL; NUCLEOLUS; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; TUMOR SUPPRESSOR GENE;

MAMMALIA;

EID: 0033000482     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(00)80351-2     Document Type: Article

References (33)

1. Alcalay, M., Tomassoni, L., Colombo, E., Stoldt, S., Grignani, F., Fagioli, M., Szekely, L., Helin, K., and Pelicci, P.G. (1998).The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein. Mol. Cell. Biol. 18, 1084-1093.
2. ARF links the tumor suppressors RB and p53. Nature 395, 124-125.
3. ARF tumor suppressor. Genes Dev. 12, 2434-2442.
4. Dyck, U.A., Maul, G.G., Miller, W.H., Chen, J.D., Kakizuka, A., and Evans, R.M. (1994). A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 76, 333-343.
5. Foulkes, W.D., Flanders, T.Y., Pollock, P.M., and Hayward, N.K. (1997). The CDK2A (p16) gene and human cancer. Mol. Med. 3, 5-20.
6. Freedman, D.A., and Levine, A.J. (1998). Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6. Mol. Cell. Biol. 18, 7288-7293.
7. Grossman, S.R., Perez, M., Kung, A.L., Joseph, M., Mansur, C., Xiao, Z.X., Kumar, S., Howley, P.M., and Linvingston, D.M. (1998). p300/MDM2 complexes participate in MDM2-mediated p53 degradation. Mol. Cell 2, 405-415.
8. Haupt, Y., Maya, R., Kazaz, A., and Oren, M. (1997). Mdm2 promotes the rapid degradation of p53. Nature 387, 296-299.
9. Hsieh, J.-K., Chan, F.S.G., O'Connor, D.J., Mittnacht, S., Zhong, S., and Lu, X. (1999). RB regulates the stability and the apoptotic function of p53 via MDM2. Mol. Cell 3, 181-193.
10. Kamb, A., Gruis, N.A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavitgian, S.V., Stockert, E., Day, R.S., Johnson, B.E., and Skolnick, M.H. (1994). A cell cycle regulator potentially involved in genesis of many tumor types. Science 264, 436-440.
11. ARF. Cell 91, 649-659.
12. Kamijo, T., Weber, J.D., Zambetti, G., Zindy, F., Roussel, M., and Sherr, C.J. (1998). Functional and physical interaction of the ARF tumor suppressor with p53 and MDM2. Proc. Natl. Acad. Sci. USA 95, 8292-8297.
13. Koh, J., Enders, G.H., Dynlacht, B.D., and Harlow, E. (1995). Tumor-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature 375, 506-510.
14. Kubbutat, M.H.G., Jones, S.N., and Vousden, K.H. (1997). Regulation of p53 stability by Mdm2. Nature 387, 299-303.
15. Lamorte, V.J., Dyck, J.A., Ochs, R.L., and Evans, R.M. (1998). Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body. Proc. Natl. Acad. Sci. USA 95, 4991-4996.
16. Levine, A. J. (1997). p53, the cellular gatekeeper for growth and division. Cell 88, 323-331.
17. Nobori, T., Mlura, K., Wu, D.J., Lois, A., Takabayashi, K., and Carson, D.A. (1994). Deletion of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368, 753-756.
18. ARF links the tumor suppressor p53 and Ras. Nature 395, 125-126.
19. Pomerantz, J., Schreiber-Agus, N., Liegeois, N.J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., and DePinho, R.A. (1998). The INK4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92, 713-723.
20. Prives, C. (1998). Signaling to p53: breaking the MDM2-p53 circuit. Cell 95, 5-8.
21. Quelle, D.E., Zindy, F., Ashmun, R., and Sherr, C.J. (1995). Alterative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83, 993-1000.
22. ARF. Proc. Natl. Acad. Sci. USA 94, 3436-3440.
23. Roth, J., Dobbelstein, M., Freedman, D.A., Shenk, T., and Levine, A.J. (1998). Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J. 17, 554-564.
24. INK4a/CDK2A tumor suppresor and its relatives. Biochim. Biophys. Acta 1378, F115-F177.
25. Serrano, M., Hannon, G.J., and Beach, D. (1993). A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 366, 704-707.
26. Sherr, C.J. (1998). Tumor surveillance via the ARF-p53 pathway. Genes Dev. 12, 2984-2991.
27. Shieh, S.-Y., Ikeda, M., Taya, Y., and Prives, C. (1997). DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91, 325-334.
28. Stommel, J.M., Marchenko, N.D., Jimenez, G.S., Moll, U.M., Hope, T.J., and Wahl, G.M. (1999). A leucine-rich export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J. 18, 1660-1672.
29. ARF, participates in a regulatory feedback loop with p53 and MDM2. EMBO J. 17, 5001-5014.
30. Weis, K., Rambaud, S., Lavau, C., Jansen, J., Carvalho, T., Carmo-Fonseca, M., Lamond, A., and Dejean, A. (1994). Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells. Cell 76, 345-356.
31. Xiao, Z., Chen, J., Levine, A.J., Modjtahedi, N., Xing, J., Sellers, W.R., and Livingston, D.M. (1995). Interaction between the retinoblastima protein and the oncoprotein MDM2. Nature 375, 694-698.
32. Zhang, Y., Xiong, Y., and Yarbrough, W.G. (1998). ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92, 725-734.
33. Zindy, F., Eischen, C.M., Randle, D.H., Kamijo, T., Cleveland, J.L., Sherr, C.J., and Roussel, M.F. (1998). Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12, 2424-2433.